Philip Oliver is a seasoned Business Development Director with over 25 years of experience in the pharmaceutical industry, currently serving as the Director and Head of Global Neuroscience Business Development and Licensing at AstraZeneca. Since 2014, they have been a Visiting Professor at University College London and an Entrepreneur in Residence at the University of Cambridge, mentoring researchers in drug and technology development. Previously, Philip held leadership roles at Eli Lilly and Company and Huntingdon Life Sciences, successfully brokering numerous collaborations and driving significant business growth. With a strong focus on innovative deal approaches and extensive networks in pharma and biotech, Philip has a proven track record in managing complex partnerships and executing strategic alliances.
This person is not in any teams
This person is not in any offices